Xvivo Perfusion AB XVIVO
OMXSTO · Sweden · Health Technology
SEK 223.60+3.40 (+1.54%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The shareholders that have appointed the members of the nomination committee represented in aggregate 29.62 percent of all shares in the company as of 31 August 2026.
CAUTION-Investigational device in the US. Limited by Federal (United States) law to investigational use.
CAUTION - Investigational device in the US. Limited by Federal (United States) law to investigational use. The safety and effectiveness of this device have not been established. The XVIVO heart technology is not commercially available in the US. GOTHENBURG, ...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.